newsfilter
← Latest News
Business Wire·

invoX Pharma Commences Tender Offer for F-star Therapeutics, Inc.

On July 7, 2022, invoX Pharma Limited ("invoX"), a wholly owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) commenced a cash tender offer for all of the issued and outstanding shares of common stock of F-star Therapeuti